| Financial Year |
March 31 2023 |
| Monetary Funds |
173,484,168.62 |
| Held-for-trading Financial Assets |
281,507.07 |
| Notes Receivable |
-- |
| Accounts Receivable |
86,322,868.73 |
| Advances to Suppliers |
2,536,199.13 |
| Other Receivables |
1,529,408.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
176,106,470.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,955,748.30 |
| Total Current Assets |
455,235,723.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,877,507.07 |
| Investment Properties |
-- |
| Fixed Assetes |
365,470,219.90 |
| Under-construction Projects |
5,040,135.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,968,269.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,860,626.76 |
| Deferred Income Tax Assets |
11,775,820.60 |
| Other Non-Current Assets |
27,720,012.15 |
| Sub-Total of Non-Current Assets |
838,381,483.76 |
| Total Assets |
1,293,617,207.18 |
| Short-Term Loans |
64,098,212.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,002,489.61 |
| Accounts Payable |
45,159,227.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,815,951.86 |
| Taxes Payable |
2,392,296.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,906,530.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
70,942,102.08 |
| Other Current Liabilities |
586,167.14 |
| Sub-Total of Current Liabilities |
274,048,498.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,376,595.08 |
| Total Liabilities |
285,425,094.03 |
| Paid-In Capital(Or Share Stock) |
256,000,000.00 |
| Capital Surplus |
297,170,708.05 |
| Surplus Reserve |
60,493,199.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
320,286,357.11 |
| Minority Stockholder's Interest |
-95,849.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,008,287,963.08 |
| Owner's Equity（Stockholder's Equity） |
1,008,192,113.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,293,617,207.18 |
